EASTWOOD BIO-MEDICAL CANADA (EBM.CA) Stock Overview
Canada - TSX-V:EBM - CA27783W1059 - Common Stock
EBM.CA Key Statistics, Chart & Performance
The current stock price of EBM.CA is 0.435 CAD. In the past month the price increased by 3.57%. In the past year, price decreased by -20.91%.
EBM.CA Competitors/Peers
Related stock screener links
About EBM.CA
Company Profile
Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-09-05. The firm is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. The firm's Eleotin products include natural remedies for certain metabolic disorders, such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. Its licensed products which have Health Canada product license numbers include Eleotin A 700, Eleotin AL88, Eleotin Cal20, Eleotin V3D, Eleotin G2000, Eleotin H55, and Eleotin Zn330. Additionally, Eleotin Bentley and Eleotin LBM have received Health Canada product license numbers. Eleotin Bentley is used to promote healthy glucose levels while Eleotin LBM is recommended for hypertension relief. The company manufactures and allocates resources towards the research and development of products.
Company Info
EASTWOOD BIO-MEDICAL CANADA
1130 - 4871 Shell Road
RICHMOND BRITISH COLUMBIA V6X 3Z6 CA
CEO: Yunji Kim
Employees: 1
Phone: 16042472100
EASTWOOD BIO-MEDICAL CANADA / EBM.CA FAQ
What is the stock price of EASTWOOD BIO-MEDICAL CANADA today?
The current stock price of EBM.CA is 0.435 CAD. The price increased by 1.16% in the last trading session.
What is the ticker symbol for EASTWOOD BIO-MEDICAL CANADA stock?
The exchange symbol of EASTWOOD BIO-MEDICAL CANADA is EBM and it is listed on the TSX Venture Exchange exchange.
On which exchange is EBM.CA stock listed?
EBM.CA stock is listed on the TSX Venture Exchange exchange.
What is EASTWOOD BIO-MEDICAL CANADA worth?
EASTWOOD BIO-MEDICAL CANADA (EBM.CA) has a market capitalization of 29.97M CAD. This makes EBM.CA a Nano Cap stock.
How many employees does EASTWOOD BIO-MEDICAL CANADA have?
EASTWOOD BIO-MEDICAL CANADA (EBM.CA) currently has 1 employees.
What are the support and resistance levels for EASTWOOD BIO-MEDICAL CANADA (EBM.CA) stock?
EASTWOOD BIO-MEDICAL CANADA (EBM.CA) has a support level at 0.43 and a resistance level at 0.45. Check the full technical report for a detailed analysis of EBM.CA support and resistance levels.
Should I buy EASTWOOD BIO-MEDICAL CANADA (EBM.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EBM.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EBM.CA, evaluating the profitability, health, valuation and growth aspects
- EASTWOOD BIO-MEDICAL CANADA (EBM.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EASTWOOD BIO-MEDICAL CANADA (EBM.CA) Sales and EPS estimates to see what analysts future expectations are.
- EASTWOOD BIO-MEDICAL CANADA (EBM.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EASTWOOD BIO-MEDICAL CANADA (EBM.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- EASTWOOD BIO-MEDICAL CANADA (EBM.CA) Stock Chart to make your own analysis
- EASTWOOD BIO-MEDICAL CANADA (EBM.CA) Latest news and press-releases to stay up to date.
Does EASTWOOD BIO-MEDICAL CANADA (EBM.CA) stock pay dividends?
EBM.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of EASTWOOD BIO-MEDICAL CANADA (EBM.CA)?
EASTWOOD BIO-MEDICAL CANADA (EBM.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
EBM.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to EBM.CA. When comparing the yearly performance of all stocks, EBM.CA is a bad performer in the overall market: 87.92% of all stocks are doing better.
EBM.CA Financial Highlights
Over the last trailing twelve months EBM.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 2.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -199.32% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |